Fluoxetine Enhances Visual Acuity in Adults with Amblyopia Under Patching: Study
Researchers have found that fluoxetine improves visual acuity significantly in adults with amblyopia under standard patching therapy. A new study was recently published in the Journal of AAPOS conducted by Arash M. and colleagues .
This was a randomized clinical trial conducted among adults aged 18 years or older diagnosed with anisometropic or strabismic amblyopia. Prior to intervention, all the participants were given standard amblyopia treatment in terms of glasses and patching for four months. Thereafter, they were randomized into two groups as follows:
• Fluoxetine Group: Given fluoxetine 20 mg/day for three months with continuation of patching.
• Placebo Group: Provided with a placebo for three months with continuation of patching.
• Baseline and after the treatment period, visual acuity and VEP parameters were measured.
The total number of participants that completed the study was 55, with 29 in the fluoxetine and 26 in the placebo group. The average age of the participants was 27.2 ± 8.6 years, ranging between 18 and 54 years.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.